Dr. Andrew Lee Rozelle, MD

Dr. Rozelle practices at Menlo Medical Clinic - Menlo Park (Crane St) in Menlo Park, California.

Dr. Rozelle's NPI, 1548326606, was assigned on December 30, 2006. Dr. Rozelle graduated from UT Southwestern Medical Center in 2002. Dr. Rozelle's California license number on file is A83950.

Dr. Rozelle's primary practice is Menlo Medical Clinic - Menlo Park (Crane St), at 1300 Crane St, Menlo Park, CA 94025. The practice phone is (650) 498-6530.

Dr. Rozelle's primary practice is Menlo Medical Clinic - Menlo Park (Crane St) in Menlo Park, California. Dr. Rozelle is also affiliated with Stanford Hospital at 300 Pasteur Drive. The medical group on file is Stanford Medicine Partners. Dr. Rozelle's employer is on file too: a breast imaging center.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rozelle practices, 2 sites in all. Vendor and product names are available with a free account.

Rheumatology is Dr. Rozelle's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Dr. Rozelle is board certified in rheumatology by the American Board of Internal Medicine. Dr. Rozelle has a license on file in California.

Dmand AI lists arteritis, arthritis, fluid in a joint, gout, joint arthropathy, joint pain, lupus and muscle pain, fibromyalgia, and limb pain among the conditions Dr. Rozelle treats.

CMS data shows 1,428 Medicare services from Dr. Rozelle across 11 procedure codes in 2024, for 361 Medicare patients. Medicare paid $97,957 for them. Every service was in an office.

CMS counts 361 Medicare patients who saw Dr. Rozelle in 2024. The largest group is 65 to 74, with 153 patients. 75% of them have arthritis, and 73% have high cholesterol. 7% are also on Medicaid. Their average risk score is 1.13, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Rozelle's median patient age at 63, with 65% women.

In 2024, Dr. Rozelle wrote 1,996 Medicare Part D claims for 326 patients. 78% of them were for generic drugs. CMS names the drug for 1,824 of them, across 37 drugs with 11 or more claims each, at $2,252,549 in total drug cost. In 2023, CMS named 2,158 claims across 40 drugs.

Dr. Rozelle accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rozelle as offering telehealth.

Dmand AI links 8 papers to Dr. Rozelle, published from 2000 to 2011. The most frequent topics are Phosphatidylinositol 4,5-Diphosphate, Actins and Cell Line. Dr. Rozelle's most frequent co-authors are Christine E. Austin, MD, Lorinda Susan Chung, MD and Mark Christopher Genovese, MD.

CMS Open Payments shows 25 general payments to Dr. Rozelle from 9 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 94% of the total. Novartis Pharmaceuticals Corporation paid the most, $275.

Dmand AI lists 2 awards for Dr. Rozelle, most recently CMS Stage 1 EHR in 2013.

Dr. Rozelle graduated from UT Southwestern Medical Center in 2002. Dr. Rozelle is a member of ACR.

Dr. Rozelle is in network with 3 carriers, including Elevance, Blue Cross Blue Shield of Michigan and CMS Medicare. HMO plans come from the most carriers, 2. Check the plan with the practice before a visit.